The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients

作者: Ji Hyung Hong , Kang San Roh , Sung-Suk Suh , Sukchan Lee , Sook Whan Sung

DOI: 10.1007/S13277-015-3428-9

关键词:

摘要: We aimed to establish whether the expression of microRNA-34a (miR-34a) is correlated with that c-MET and G1 phase regulators such as cyclin dependent kinase (CDK) 4, CDK6, D (CCND) 1 in non-small cell lung cancer (NSCLC), a relationship exists between miR-34a both clinicopathologic factors recurrence-free survival (RFS). For 58 samples archived from NSCLC patients, we measured c-MET, CDK4/6, CCND1 by quantitative RT-PCR assessed expression, clinicopathological factors, RFS. The was significantly lower squamous tumors (P < 0.001) associated lymphatic invasion (P = 0.001). found significant inverse correlations (R = -0.316, P = 0.028) CDK6 (R = -0.4582, P = 0.004). RFS were longer adenocarcinoma patients high than those low (55.6 vs. 21.6 months; P = 0.020). With univariate analysis, statistically prognostic for (Relative risk (RR), 8.14; P = 0.049), TNM stage (RR, 13.55; P = 0.001), LN metastasis 4.19; P = 0.043), presence 7.05; P = 0.015). In multivariate only 11.5; P = 0.027). inversely NSCLC, had significance RFS, especially patients.

参考文章(51)
Dicle Guc, Emin Kansu, Ergun Karaagaoglu, Munevver Moran, Fusun Ozmen, Evren Ozdemir, M Mahir Ozmen, Selda Seçkin, Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer. World Journal of Gastroenterology. ,vol. 17, pp. 3220- 3228 ,(2011) , 10.3748/WJG.V17.I27.3220
Aurora Esquela-Kerscher, Frank J. Slack, Oncomirs — microRNAs with a role in cancer Nature Reviews Cancer. ,vol. 6, pp. 259- 269 ,(2006) , 10.1038/NRC1840
Bassel S Al-Alao, Kathy Gately, Siobhan Nicholson, Eilis McGovern, Vincent K Young, Kenneth J O'Byrne, Prognostic impact of vascular and lymphovascular invasion in early lung cancer Asian Cardiovascular and Thoracic Annals. ,vol. 22, pp. 55- 64 ,(2014) , 10.1177/0218492313478431
Soichiro Yamamura, Sharanjot Saini, Shahana Majid, Hiroshi Hirata, Koji Ueno, Guoren Deng, Rajvir Dahiya, MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells PLoS ONE. ,vol. 7, pp. e29722- ,(2012) , 10.1371/JOURNAL.PONE.0029722
HAIEN ZHAO, BAOAN MA, YUCAI WANG, TAO HAN, LIANHE ZHENG, CONG SUN, TAO LIU, YINGLONG ZHANG, XIUCHUN QIU, QINGYU FAN, miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. Oncology Reports. ,vol. 29, pp. 1027- 1036 ,(2013) , 10.3892/OR.2013.2234
Sang-Won Hong, Kyung-Hee Jung, Byung Hee Park, Hong-Mei Zheng, Hee-Seung Lee, Myung-Joo Choi, Jeong In Yun, Nam Sook Kang, Jongkook Lee, Soon-Sun Hong, KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer Cancer Letters. ,vol. 332, pp. 74- 82 ,(2013) , 10.1016/J.CANLET.2013.01.015
Arash Javeri, Massoud Ghaffarpour, Masoumeh Fakhr Taha, Massoud Houshmand, Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Medical Oncology. ,vol. 30, pp. 413- 413 ,(2013) , 10.1007/S12032-012-0413-7
Jason F. Wiggins, Lynnsie Ruffino, Kevin Kelnar, Michael Omotola, Lubna Patrawala, David Brown, Andreas G. Bader, Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Research. ,vol. 70, pp. 5923- 5930 ,(2010) , 10.1158/0008-5472.CAN-10-0655
Danae Papadogianni, Nikolaos Soulitzis, Demetrios Delakas, Demetrios A. Spandidos, Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence Tumor Biology. ,vol. 35, pp. 2481- 2489 ,(2014) , 10.1007/S13277-013-1328-4